With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.918870-76-5,Dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene][[5-[(dimethylamino)sulfonyl]-2-(1-methylethoxy-O)phenyl]methylene-C]ruthenium(II),as a common compound, the synthetic route is as follows.,918870-76-5
Example 103 Synthesis of Ru complex 6h The Ru complex (Zhan catalyst 2b, l.Ommol) and a new ligand 5h (1.5mmol) were dissolved in 20 mL of anhydrous DCM and reacted directly to form the desired Ru complex 6h in the preaence of CuCl (3.0mmol) in a 100 mL of three-neck flask filled with inert gas (Ar). The reaction mixture was stirred for 0.5 hr at room temperature. After complete, the reaction solution was filtered and purified by flask column. 378mg of yellow-green solid product 6h was obtained, yield: 52%. Ru complex 6h is confirmed by 1HNMR (400 MHz, CDC13): delta 16.52 (s, 1H, Ru=CH), 8.43 (s, 1H, N=CH), 8.10 (s, 1H), 7.46-7.22 (m, 2H), 7.73-6.96 (m, 8H), 4.19 (s, 4H, NCH2CH2N), 3.95 (s, 3H), 3.87 (s, 3H), 2.49 (s, 12H), 2.48 (s, 6H).
As the paragraph descriping shows that 918870-76-5 is playing an increasingly important role.
Reference£º
Patent; ZANNAN SCITECH CO., LTD.; ZHAN, James Zheng-Yun; WO2011/79439; (2011); A1;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI